International Journal of Cancer Management

Published by: Kowsar

Triple Negative Breast Cancer in Iranian Women: Clinical Profile and Survival Study

Amir Shahram Yousefi Kashi 1 , Sharareh Yazdanfar 2 , Mohammad-Esmaeil Akbari 3 and Afshin Rakhsha 1 , *
Authors Information
1 Cancer Research Center, Faculty of Medicine, Shahid Beheshti Univeristy of Medical Sciences, Tehran, IR Iran
2 Department of Radiation Oncology, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Cancer Research Center, Shahid Beheshti Univeristy of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: August 2017, 10 (8); e10471
  • Published Online: May 2, 2017
  • Article Type: Research Article
  • Received: January 10, 2017
  • Revised: February 4, 2017
  • Accepted: April 29, 2017
  • DOI: 10.5812/ijcm.10471

To Cite: Yousefi Kashi A S, Yazdanfar S, Akbari M, Rakhsha A. Triple Negative Breast Cancer in Iranian Women: Clinical Profile and Survival Study, Int J Cancer Manag. 2017 ; 10(8):e10471. doi: 10.5812/ijcm.10471.

Abstract
Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5)-86[DOI][PubMed]
  • 2. Yavari P, Hislop TG, Bajdik C, Sadjadi A, Nouraie M, Babai M, et al. Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev. 2006; 7(1): 86-90[PubMed]
  • 3. Harold J, Burstein JRH, In DeVita VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. 2011; : 1401-46
  • 4. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A. 1999; 96(16): 9212-7[PubMed]
  • 5. Bertucci F, Finetti P, Birnbaum D. Basal breast cancer: a complex and deadly molecular subtype. Curr Mol Med. 2012; 12(1): 96-110[PubMed]
  • 6. Yousefi Kashi ASH, Mofid B, Mirzaei HR, Azadeh P. Overall survival and related prognostic factors in metastatic brain tumor treated with whole brain radiation therapy. J Res Med Sci. 2010; 4: 213-16[DOI][PubMed]
  • 7. Akasbi Y, Bennis S, Abbass F, Znati K, Joutei KA, Amarti A, et al. Clinicopathological, therapeutic and prognostic features of the triple-negative tumors in moroccan breast cancer patients (experience of Hassan II university hospital in Fez). BMC Res Notes. 2011; 4: 500[DOI][PubMed]
  • 8. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295(21): 2492-502[DOI][PubMed]
  • 9. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007; 13(15 Pt 1): 4429-34[DOI][PubMed]
  • 10. Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, et al. The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control. 2009; 20(7): 1071-82[DOI][PubMed]
  • 11. Rakhsha A, Yousefi Kashi AS, Hoseini SM. Evaluation of Survival and Treatment Toxicity With High-Dose-Rate Brachytherapy With Cobalt 60 in Carcinoma of Cervix. Iran J Cancer Prev. 2015; 8(4)[DOI][PubMed]
  • 12. Amirikia KC, Mills P, Bush J, Newman LA. Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations. Cancer. 2011; 117(12): 2747-53[DOI][PubMed]
  • 13. Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK, Potter J, et al. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res. 2011; 17(5): 1082-9[DOI][PubMed]
  • 14. Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U, Harbeck N. Triple-negative breast cancer--current status and future directions. Ann Oncol. 2009; 20(12): 1913-27[DOI][PubMed]
  • 15. Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2006; 24(36): 5652-7[DOI][PubMed]
  • 16. Dawson SJ, Provenzano E, Caldas C. Triple negative breast cancers: clinical and prognostic implications. Eur J Cancer. 2009; 45 Suppl 1: 27-40[DOI][PubMed]
  • 17. Yousefi Kashi AS, Khaledi S, Houshyari M. CT Simulation to Evaluate of Pelvic Lymph Node Coverage in Conventional Radiotherapy Fields Based on Bone and Vessels Landmarks in Prostate Cancer Patients. J Cancer Prev. 2016; 9(3)[DOI][PubMed]
  • 18. Coleman RE. Skeletal complications of malignancy. Cancer. 1997; 80(8 Suppl): 1588-94[PubMed]
  • 19. Yi.icel B, Bahar S, Karan T, Eker M, Celasun MA. Importance of metastasis site in survival of patients with breast cancer. J Med Oneal. 2014; 1(2): 7
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments